Get startedLog in
    Picture of Cidara Therapeutics logo

    CDTX — Cidara Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeLarge CapNeutral
    All News

    Brief: Cidara Therapeutics Reacquires Global Development And Commercial Rights To CD388

    Picture of Cidara Therapeutics logoCidara Therapeutics
    24/04/2024 21:14
    April 24 (Reuters) - Cidara Therapeutics Inc  CDTX.O :
    * CIDARA THERAPEUTICS REACQUIRES GLOBAL DEVELOPMENT AND
COMMERCIAL
RIGHTS TO CD388 AND ANNOUNCES PRIVATE PLACEMENT FINANCING OF
$240 MILLION
    * CIDARA THERAPEUTICS- FOR EXCLUSIVE GLOBAL DEVELOPMENT,
COMMERCIAL RIGHTS TO CD388, JOHNSON & JOHNSON GOT ONE-TIME
UPFRONT PAYMENT OF $85 MILLION FROM CO

Source text for Eikon:  ID:nGNX52QfFz 
Further company coverage:  CDTX.O 

 (Reuters.Briefs@thomsonreuters.com)

    Recent news on Cidara Therapeutics

    See all news